Financial News
Exact Sciences Cor (NQ: EXAS )
130.04
USD
-0.48
(-0.37%)
Official Closing Price
Updated: 4:21 PM EDT, Apr 16, 2021
Add to My Watchlist
Press releases about Exact Sciences Cor
From PR Newswire
Exact Sciences schedules first quarter 2021 earnings call
April 08, 2021
From PR Newswire
Exact Sciences to participate in March investor conferences
February 22, 2021
From PR Newswire
Exact Sciences to Acquire Ashion Analytics and Enter Research Collaboration with City of Hope's Genomics Institute, TGen
February 16, 2021
From PR Newswire
Exact Sciences Announces Fourth Quarter 2020 Results
February 16, 2021
From PR Newswire
Thinking about trading options or stock in Nvidia, General Electric, Nio, EXACT Sciences, or Paypal?
February 16, 2021
From PR Newswire
Catalio Capital Management Launches Credit Opportunities Strategy
February 02, 2021
Exact Sciences schedules fourth quarter 2020 earnings call
February 01, 2021
From PR Newswire
Exact Sciences to participate in February investor conferences
February 01, 2021
From PR Newswire
Exact Sciences Licenses Targeted Digital Sequencing Method to Extend Leadership in Precision Oncology
January 13, 2021
From PR Newswire
New Prospective Data Demonstrate Low False-Positive Rate for Screening Average-Risk People Age 45-49 for Colorectal Cancer with Cologuard®
January 12, 2021
From PR Newswire
Should you invest in Exxon Mobil, Wells Fargo, General Motors, Etsy, or EXACT Sciences?
January 12, 2021
From PR Newswire
Exact Sciences Announces Preliminary Fourth Quarter 2020 Results
January 10, 2021
From PR Newswire
Exact Sciences Completes Acquisition of Thrive Earlier Detection, Creating a Leader in Blood-Based, Multi-Cancer Screening
January 05, 2021
From PR Newswire
Exact Sciences to participate in J.P. Morgan Healthcare Conference
December 28, 2020
From PR Newswire
Cognitive Assessment & Training in Healthcare Market Could Reach $45 Billion by 2026
December 23, 2020
Tags
Featured News
Cognitive Assessment & Training in Healthcare Market Could Reach $45 Billion by 2026
December 23, 2020
From PR Newswire
New Data at SABCS 2020 Highlight the Role of the Oncotype DX Breast Recurrence Score® Test in Shaping Clinical Practice
December 11, 2020
From PR Newswire
RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer
December 09, 2020
From PR Newswire
Exact Sciences to participate in December investor conference
November 23, 2020
From PR Newswire
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)
November 17, 2020
From PR Newswire
Exact Sciences to participate in November investor conferences
November 02, 2020
From PR Newswire
Thinking about buying stock in Apple, Titan Pharmaceuticals, Tupperware Brands, EXACT Sciences, or Roku?
October 28, 2020
From PR Newswire
Exact Sciences Commends Task Force for Draft Updated Guidelines that include Colorectal Cancer Screening Beginning at Age 45
October 27, 2020
From PR Newswire
Thinking about buying stock in Xilinx, General Electric, EXACT Sciences, Harley-Davidson, or American International?
October 27, 2020
From PR Newswire
Exact Sciences Announces Entry into Agreements to Sell $869 Million of Common Stock in Registered Direct Offering
October 27, 2020
From PR Newswire
Exact Sciences Announces Third Quarter 2020 Results
October 27, 2020
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.